[company_age]11.0[/company_age][employees]51-200 employees[/employees][funding]Series A[/funding][description]Dynamic Biosensors is a leading innovator in the field of biomolecular interaction analysis, empowering researchers with cutting-edge instruments and consumables for advanced analysis on biochips and single cells. Their offerings enable breakthroughs in drug discovery, life science research, and cell & gene therapies, propelling advancements in these critical areas. Headquartered in Munich, Germany, a hub of Europe's biotechnology industry, Dynamic Biosensors operates globally with offices in the United States, the United Kingdom, France, Poland, Portugal, Japan, and Singapore. The company's unique value proposition lies in its heliX® platform, offering specialized biosensors tailored to researchers' specific needs for uncovering molecular interactions. Dynamic Biosensors' technologies excel in analytical capabilities, paving the way for the development and manufacturing of future drugs. Their heliX and heliX+ instruments provide unparalleled detail in characterizing molecular interactions, enabling a comprehensive understanding of biological processes. Additionally, the heliXcyto instrument specializes in measuring binding kinetics directly on cells, preserving the complexity of the native environment, offering researchers a unique advantage. Dynamic Biosensors' commitment to supporting scientists in their endeavors to accelerate the drug discovery process sets them apart as a valuable partner in the scientific community.[/description][ps]Instruments and consumables for advanced analysis of biomolecular interactions on biochips and single cells, including the heliX® platform, heliX® biosensor instruments, heliX® chip, heliOS® software, and proFIRE® instrument.[/ps]